Evommune, Inc. (EVMN) Stock Forecast & Price Target

Compare

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

EVMN Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Evommune,

Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

EVMN Stock 12 Month Forecast

Average Price Target

$39.33

▲(123.59% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Evommune, Inc. in the last 3 months. The average price target is $39.33 with a high forecast of $42.00 and a low forecast of $36.00. The average price target represents a 123.59% change from the last price of $17.59.

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

Highest Price Target$42.00

Average Price Target$39.33

Lowest Price Target$36.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt Phipps

William Blair

Buy

―

Reiterated

12/20/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gavin Clark-Gartner

Evercore ISI

$40

Buy

127.40%

Upside

Reiterated

12/18/25

Evercore ISI Sticks to Its Buy Rating for Evommune, Inc. (EVMN)

Judah Frommer

Morgan Stanley

$36

Buy

104.66%

Upside

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN), Evommune, Inc. (NYSE: EVMN) and Eli Lilly & Co (NYSE: LLY)

Thomas Smith

Leerink Partners

$42

Buy

138.77%

Upside

Initiated

12/01/25

Evommune initiated with an Outperform at LeerinkEvommune initiated with an Outperform at Leerink

Prakhar Agrawal

Cantor Fitzgerald

Buy

―

Initiated

12/01/25

Evommune initiated with an Overweight at Cantor FitzgeraldEvommune initiated with an Overweight at Cantor Fitzgerald

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt Phipps

William Blair

Buy

―

Reiterated

12/20/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gavin Clark-Gartner

Evercore ISI

$40

Buy

127.40%

Upside

Reiterated

12/18/25

Evercore ISI Sticks to Its Buy Rating for Evommune, Inc. (EVMN)

Judah Frommer

Morgan Stanley

$36

Buy

104.66%

Upside

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN), Evommune, Inc. (NYSE: EVMN) and Eli Lilly & Co (NYSE: LLY)

Thomas Smith

Leerink Partners

$42

Buy

138.77%

Upside

Initiated

12/01/25

Evommune initiated with an Outperform at LeerinkEvommune initiated with an Outperform at Leerink

Prakhar Agrawal

Cantor Fitzgerald

Buy

―

Initiated

12/01/25

Evommune initiated with an Overweight at Cantor FitzgeraldEvommune initiated with an Overweight at Cantor Fitzgerald

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evommune, Inc.

1 Month

xxx

Success Rate

0/1 ratings generated profit

Average Return

-12.70%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -12.70% per trade.

3 Months

xxx

Success Rate

0/1 ratings generated profit

Average Return

-12.70%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -12.70% per trade.

1 Year

Matt PhippsWilliam Blair

Success Rate

0/1 ratings generated profit

Average Return

-12.70%

reiterated a buy rating 8 days ago

Copying Matt Phipps's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.70% per trade.

2 Years

xxx

Success Rate

0/1 ratings generated profit

Average Return

-12.70%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -12.70% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EVMN Analyst Recommendation Trends

Rating

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, EVMN has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EVMN average Analyst price target in the past 3 months is 39.33.

Each month's total comprises the sum of three months' worth of ratings.

EVMN Financial Forecast

EVMN Earnings Forecast

Next quarter’s earnings estimate for EVMN is -$6.08 with a range of -$12.16 to -$0.61. The previous quarter’s EPS was -$8.07. EVMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year EVMN has Performed in-line its overall industry.

EVMN Sales Forecast

Next quarter’s sales forecast for EVMN is $3.33M with a range of $0.00 to $10.00M. The previous quarter’s sales results were $10.00M. EVMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year EVMN has Performed in-line its overall industry.

EVMN Stock Forecast FAQ

What is EVMN’s average 12-month price target, according to analysts?

Based on analyst ratings, Evommune, Inc.’s 12-month average price target is 39.33.

What is EVMN’s upside potential, based on the analysts’ average price target?

Evommune, Inc. has 123.59% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is EVMN a Buy, Sell or Hold?

Evommune, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is Evommune, Inc.’s price target?

The average price target for Evommune, Inc. is 39.33. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $42.00 ,the lowest forecast is $36.00. The average price target represents 123.59% Increase from the current price of $17.59.

What do analysts say about Evommune, Inc.?

Evommune, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of EVMN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Evommune, Inc. (EVMN) Stock Forecast & Price Target

EVMN Analyst Ratings

EVMN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Evommune, Inc.

EVMN Analyst Recommendation Trends

EVMN Financial Forecast

EVMN Earnings Forecast

EVMN Sales Forecast

EVMN Stock Forecast FAQ

Detailed List of Analyst Forecasts